BackEnanta Pharmaceuticals Overview

Enanta Pharmaceuticals Total Liabilities

Latest total liabilities for ENTA: $200M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$195.80M
↓ 11.70% YoYΔ $-25.95M vs prior year quarter

Peer trimmed avg / median

Loading

Enanta Pharmaceuticals Total Liabilities History

Loading

Enanta Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

Enanta Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Enanta Pharmaceuticals (ENTA) FAQ

As of the most recent data (June 2026), ENTA shows a total liabilities of $200M. That compares with $220M in the prior-year period — down 11.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENTA's total liabilities is now $200M (was $220M) — a 11.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Enanta Pharmaceuticals is outperforming or lagging.

Tracking ENTA's total liabilities over time shows whether Enanta Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $220M in the prior-year period — down 11.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Enanta Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $200M) with ownership activity and broader fundamentals.

Enanta Pharmaceuticals's total liabilities is $200M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.